Search

everythinglearnresearchcommunity

for

Search:↓

The combination therapy is effective and well-tolerated for treating esophageal cancer.

Gemcitabine and paclitaxel are effective and safe as first-line treatment for metastatic breast cancer.

GC10/DOX hydrogel shows promise as an effective thyroid cancer treatment.

Radiation therapy successfully treated an elderly man's skin cancer and pre-cancerous scalp lesions.

Radiation therapy successfully treated an elderly man's skin cancer and pre-cancerous scalp lesions.

Low-intensity ultrasound may prevent hair loss during taxane chemotherapy.

Combining hair transplantation with PRP is more effective for treating hair loss than hair transplantation alone.

Combining either fractional CO2 laser or microneedling with 5-FU is more effective for treating vitiligo.

Pemigatinib may be effective for treating ZMYM2::FGFR1 fusion-positive leukemia.

A woman kept her eyelashes during chemotherapy possibly because of her glaucoma eye drops.

Isolated limb perfusion is a safe and effective treatment for limb melanoma.

Isolated hyperthermic chemotherapy perfusion for limb melanoma is safe and effective with manageable side effects.

Scalp cooling is the only FDA-approved method to prevent hair loss from chemotherapy, but other treatments like minoxidil and PRP are being tested.

Targeting EGFR may help reduce hair loss from chemotherapy.

The treatment is safe and effective for elderly patients with advanced non-small-cell lung cancer.

Combining fractional CO2 laser or microneedling with 5-FU is more effective and safer for treating vitiligo.

Intravenous arsenic is safe and effective for treating certain blood cancers.

Facebook groups play a crucial role in supporting and guiding patients on scalp cooling and hair loss during chemotherapy.

Bortezomib chemotherapy can cause temporary skin rashes.

ALRN-6924 may prevent hair loss caused by chemotherapy.

Sorafenib can cause a unique skin reaction.

Some early breast cancer patients have long-term hair loss after chemotherapy, especially older and postmenopausal women.

Chemotherapy in the first trimester of pregnancy is risky, but in the second and third trimesters, it's generally safe with careful drug selection and timing.

Topical calcitriol-analogs can reduce hair loss caused by chemotherapy.

Oral paclitaxel plus encequidar improved tumor response and caused less neuropathy but more serious infections than intravenous paclitaxel.

Chemotherapy often causes hair loss, which is distressing for many, but usually reversible.

Chemotherapy with carboplatin-paclitaxel causes hair loss in all patients.

Most children with CNS tumors on targeted therapy had skin reactions, which were generally treatable without stopping the therapy.